Your browser doesn't support javascript.
loading
Novel NARS2 variant causing leigh syndrome with normal lactate levels.
Tanaka, Ryosuke; Takeguchi, Ryo; Kuroda, Mami; Suzuki, Nao; Makita, Yoshio; Yanagi, Kumiko; Kaname, Tadashi; Takahashi, Satoru.
Afiliación
  • Tanaka R; Department of Pediatrics, Asahikawa Medical University, Asahikawa, Japan. ryot5p@asahikawa-med.ac.jp.
  • Takeguchi R; Department of Pediatrics, Asahikawa Medical University, Asahikawa, Japan.
  • Kuroda M; Department of Pediatrics, Asahikawa Medical University, Asahikawa, Japan.
  • Suzuki N; Department of Pediatrics, Asahikawa Medical University, Asahikawa, Japan.
  • Makita Y; Department of Genetic Counseling, Asahikawa Medical University Hospital, Asahikawa, Japan.
  • Yanagi K; Department of Genome Medicine, National Center for Child Health and Development, Tokyo, Japan.
  • Kaname T; Department of Genome Medicine, National Center for Child Health and Development, Tokyo, Japan.
  • Takahashi S; Department of Pediatrics, Asahikawa Medical University, Asahikawa, Japan.
Hum Genome Var ; 9(1): 12, 2022 May 04.
Article en En | MEDLINE | ID: mdl-35508527
ABSTRACT
Leigh syndrome is the most genetically heterogenous phenotype of mitochondrial disease. We describe a patient with Leigh syndrome whose diagnosis had not been confirmed because of normal metabolic screening results at the initial presentation. Whole-exome sequencing identified pathogenic variants in NARS2, the gene encoding a mitochondrial asparaginyl-tRNA synthetase. One of the biallelic variants was novel. This highlights the essential role of genetic testing for a definite diagnosis of Leigh syndrome.